paralysis (TPP) and stated that a literature review indicated this to be 'the first reported case in a Caucasian Briton'. In fact, TPP was first recognized in the United Kingdom in 1938 (Brain 1938 and by 1975 had been reported on at least sixoccasions; Sir, There is a widespread view that the administration of aspirin may be associated with haematemesis and melaena in an appreciable number of users. The minority viewpoint (Langman 1974 (Langman , 1975 is that no study has compared bleeding patients with adequate controls, that the proportion of patients taking aspirin before bleeding varies widely between series, and that admissions for acute bleeding in the UK have risen whilst aspirin sales have fallen.
The debate has been rekindled by recent data from the Boston Collaborative Drug Surveillance Program (lick & Porter 1978) suggesting that, in hospitalized patients, aspirin administration in a seven-day period is followed by gastric bleeding sufficient to warrant blood transfusion in 0.3% of patients and by lesser bleeding not requiring blood transfusion in another 1.6% of patients. Langman has pointed out that the findings must not be extrapolated from patients already hospitalized for something else to well citizens, as the resulting numbers lire too large (Langman 1978) .
The Boston Collaborative Drug Surveillance Program (Levy 1974) has shown that bleeding in the absence of a demonstrable lesion is not associated with aspirin taken on 0-3 days per week, but strongly associated with more frequent use. This point raises a fallacy present in many studies -the failure to distinguish between aspirin taken solely before bleeding and aspirin taken regularly (Duggan 1970) . Data from 492 admissions to the Royal Newcastle Hospital for bleeding attributed to chronic gastric or duodenal ulcer or acute lesions show no association between a substantial but not regular intake of aspirin within forty-eight hours of bleeding, and acute lesions.
It is important then to have an assessment of the risk of overt bleeding from the acute gastric mucosal lesion produced by aspirin in non-hospitalized persons. Estimates are possible if some assumptions are made as to aspirin consumption and the incidence of bleeding gastric lesions.
Let us suppose that the aspirin-taking habits of the Newcastle community of 215000 people aged fifteen years and over (1976census) are the same as those in the nearest two large cities to the north and south, Sydney and Brisbane, for which data are available (Unisearch 1968). (It is likely that this is a serious underestimate as analgesic nephropathy acounts for 57% of admissions to the National Dialysis Program in Newcastle as against 34% for the whole of NSW.) Then the estimated consumption of aspirin containing preparations is about 16x 10 6 doses annually. On the other hand, Rainsford (197I) has estimated the sales of aspirin at 0.63 doses per head per day in Australia or 67 x 10 6 for this community of 290000 persons. There are then two estimates of annual consumption: a low one of 16x 10 6 doses and a high of 67 x 10 6 doses -say 50 x 10 6 doses.
If we suppose that 15%of adults take aspirin on at least four days weekly in accordance with Unisearch data, and that the estimate of risk (Levy 1974)of 15 per 100000 taking aspirin on at least four days weekly applies, then the annual incidence of episodes of aspirin-related bleeding lesions is 15 per 100000 x 15% of 215000=5 episodes per annum. The estimated risk is then 5 episodes/50 x 10 6 doses or O. I episode/million doses.
The estimated total admissions for acute upper gastrointestinal bleeding to the three public hospitals in Newcastle in 1976 were 256 (Royal Newcastle Hospital 160, Newcastle Mater Hospital 63, Wallsend District Hospital 33). If the proportion due to acute erosion found at the Royal Newcastle Hospital applied elsewhere, then there were about 40 admissions for bleeding erosion and an unknown number due to bleeding erosions in patients with chronic peptic ulcer which was not bleeding, say 10. The maximal risk of bleeding following a dose of aspirin is that which would occur if it is assumed that all bleeding erosions were due to aspirin and the minimal estimate of the aspirin intake is used: thus ± 3 per million doses.
Thus there are two estimates of the risk of overt bleeding requiring hospital admission following a dose of aspirin: a low estimate of 0.1 episodes per million doses; and a maximal estimate of 3 per million doses. 
